CRBUCaribou Biosciences Inc. Common Stock

1.660USD+1.22%Mkt Cap: 177.96M $P/E:

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISP…

Key Statistics

Company
Market Cap177.96M $
Enterprise Value86.95M $
Revenue (TTM)10.04M $
Gross Profit-73.82M $
Net Income (TTM)-148.13M $
Revenue/Share0.1040 USD
Last Price1.660 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees97
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-1.27
PEG
EV/EBITDA-0.83
EV/Revenue8.66
P/S17.20
P/B1.53
EPS (TTM)-1.06
EPS (Forward)-1.26
52W Range
1.38013% of range3.535
52W High3.535 USD
52W Low1.380 USD
Profitability
Gross Margin0.00%
Oper. Margin-1690.39%
EBITDA Margin0.00%
Profit Margin-1327.40%
ROE-121.24%
ROA-84.47%
Growth
Revenue Growth-43.80%
Earnings Growth
Cash Flow & Leverage
Operating CF-110.99M $
CapEx (TTM)1.36M $
FCF Margin-593.98%
FCF Yield-33.49%
Net Debt-85.66M $
Net Debt/EBITDA0.82
Balance Sheet
Debt/Equity0.22
Current Ratio6.49
Quick Ratio6.36
Book Value/Sh1.052 USD
Cash/Share1.048 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)11.86 USD
Upside (mean)+614.3%
Target Range4.000 USD32.00 USD
$4.000+614.3% to mean$32.00
# Analysts7
Ownership
Shares Out.107.21M
Float102.84M
Insiders8.24%
Institutions44.85%
Short Interest
Short Ratio6.7d
Short % Float12.22%
Short % Out.11.74%
Shares Short11.64M
Short (prev mo.)9.63M
Technical
SMA 501.668 (-0.5%)
SMA 2001.820 (-8.8%)
Beta2.28
S&P 52W Chg18.16%
Avg Vol (30d)1.29M
Avg Vol (10d)958.21K
Technical Indicators
RSI (14)51.8
MACD-0.0170
MACD Signal-0.0306
MACD Hist.+0.0136
BB Upper1.735 USD
BB Middle1.590 USD
BB Lower1.445 USD
BB Width18.25%
ATR (14)0.0844 USD
Vol Ratio (20d)1.09x